HV-101
Phase 1- Indications
- Recurrent solid tumors, Metastatic solid tumors
Company intelligence / Profile preview
Hervor Therapeutics
Zhejiang Sheng, Chinapmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Hervor Therapeutics has one known clinical-stage program (HV‑101) in Phase 1 trials targeting advanced malignant solid neoplasms using TIL cell therapy. No published clinical results are available as of the latest update.[1][2] - The company appears to be early-stage with a focused pipeline. - No additional programs or late-stage assets are reported. - The company was founded in 2021 and operates out of Zhejiang Sheng, China.[1][2]
- Therapeutic areas
- Oncology
- Modalities
- TIL therapy (Tumor-Infiltrating Lymphocyte therapy)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Guangdong Tcrcure Biopharma Technology Co. Ltd. listed as an "Active Org." for HV‑101 program,[*] suggesting collaboration or partnership on this asset.[*]
Beyond the preview
Go deeper on Hervor Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hervor Therapeutics.